Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenomatous Polyps × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 5 Prostatic Neoplasms 2 Precancerous Conditions 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Osteosarcoma 1 Neoplasms 1 Medulloblastoma 1 Keratosis, Actinic 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Metformin 1 Erlotinib Hydrochloride 1 Eflornithine 1 Cholecalciferol 1 Calcium 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00983580 2019-09-04

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Completed

107 enrolled 10 charts

Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡